| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.087 | 0.003 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.13 | 0.004 |